These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2810438)

  • 1. Observation of activity of IL-2 produced by mononuclear cells in tumor draining lymph-node.
    Fang JM; Bi AH
    J Tongji Med Univ; 1989; 9(2):91-4. PubMed ID: 2810438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.
    Kusugami K; Matsuura T; Kawase T; Ina K; Matsunaga H; Kuwahara Y; Inagaki T; Morise K; Shimokata K
    Gastroenterol Jpn; 1990 Jun; 25(3):306-13. PubMed ID: 1972685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
    Koba F; Akiyoshi T; Tsuji H
    J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients.
    Karimine N; Arinaga S; Inoue H; Nanbara S; Ueo H; Akiyoshi T
    Clin Exp Immunol; 1994 Jun; 96(3):484-90. PubMed ID: 8004819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.
    Eremin O; Ashby J; Stephens JP
    Int J Cancer; 1978 Jan; 21(1):35-41. PubMed ID: 342425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated killer cell activity in lymph nodes.
    Akiyoshi T; Koba F; Tsuji H
    J Clin Lab Immunol; 1987 Feb; 22(2):91-5. PubMed ID: 3496459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.
    Bonilla F; Alvarez-Mon M; Merino F; de la Hera A; Alés JE; España P; Durántez A
    Cancer; 1988 Feb; 61(4):629-34. PubMed ID: 3257405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
    Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
    Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
    Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
    Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432].
    Nakajima Y; Akimoto M; Kimura M; Matano S; Hirakawa H; Kasai M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2766-71. PubMed ID: 2428312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.
    Koba F; Akiyoshi T; Arinaga S; Wada T; Tsuji H
    Jpn J Surg; 1987 Mar; 17(2):83-90. PubMed ID: 2957537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super natural killer cells that target metastases in the tumor draining lymph nodes.
    Chandrasekaran S; Chan MF; Li J; King MR
    Biomaterials; 2016 Jan; 77():66-76. PubMed ID: 26584347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
    Gibson PR; Jewell DP
    Clin Exp Immunol; 1985 Jul; 61(1):160-8. PubMed ID: 2412737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients.
    Dewan MZ; Takada M; Terunuma H; Deng X; Ahmed S; Yamamoto N; Toi M
    Biomed Pharmacother; 2009 Nov; 63(9):703-6. PubMed ID: 19269774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of specific CTL by DC from axillary lymph node of patients with breast cancer].
    Liu YJ; Zhang JL; Shan BE
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):60-2. PubMed ID: 17210110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
    Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic injection of C-class CpG ODN in draining lymph node area induces potent activation of immune cells and rejection of established breast cancer in mice.
    Yang L; Sun L; Wu X; Wang L; Wei H; Wan M; Zhang P; Yu Y; Wang L
    Clin Immunol; 2009 Jun; 131(3):426-37. PubMed ID: 19233733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes.
    Arabpour M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
    Mol Immunol; 2019 Oct; 114():172-178. PubMed ID: 31357083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.